研究简报

一种氟代丁酸腺苷衍生物的合成

  • 姚后宗 ,
  • 尹伟 ,
  • 陈晶磊 ,
  • 乔春华
展开
  • a. 苏州大学药学院 苏州 215123;
    b. 中国药科大学新药研究中心 南京 210009

收稿日期: 2013-11-05

  修回日期: 2014-01-20

  网络出版日期: 2014-03-03

基金资助

国家自然科学基金(No. 81072514)和国家自然青年科学基金(No. 21002067)资助项目.

Rational Design and Synthesis of a Fluorinated Butyric Adenosine Derivative

  • Yao Houzong ,
  • Yin Wei ,
  • Chen Jinglei ,
  • Qiao Chunhua
Expand
  • a. College of Pharmaceutical Science, Soochow University, Suzhou 215123;
    b. Center for Drug Discovery, China Pharmaceutical University, Nanjing 210009

Received date: 2013-11-05

  Revised date: 2014-01-20

  Online published: 2014-03-03

Supported by

Project supported by the National Natural Science Foundation of China (No. 81072514) and the National Natural Science Foundation for Young Scientists of China (No. 21002067).

摘要

泛酸合成酶(Pantothenate Synthetase,PS)是结核杆菌泛酸合成途径中的一个关键酶,成为抗结核药物合适靶位. 根据泛酸合成酶催化的反应中间体和生物电子等排原理,用酰基磺酰胺取代不稳定的酰基磷酸接合子,以泛酸内酯和腺苷为原料,通过9步反应合成了5-O-{[(R)-4-氟-2-羟基-3,3-二甲基丁酰基]磺酰胺基}腺苷(1). 所合成化合物的结构都经1H NMR,13C NMR和HRMS表征确认.

本文引用格式

姚后宗 , 尹伟 , 陈晶磊 , 乔春华 . 一种氟代丁酸腺苷衍生物的合成[J]. 有机化学, 2014 , 34(6) : 1222 -1226 . DOI: 10.6023/cjoc201311005

Abstract

Pantothenate synthetase (PS), the key enzyme in the biosynthesis of the pantothenate acid, is considered to be a new target for anti-tuberculosis drug development. Based on the structure of the enzyme catalyzed reaction intermediate and bioisosterism principle, 5'-O-{[(R)-4-fluoro-2-hydroxy-3,3-dimethylbutanoyl]sulfamoyl}adenosine (1) was designed with the sulfamate isoster to replace the unstable phosphate moiety. The synthesis of this compound was achieved using pantolactone and adenosine as the starting materials through 9 steps of reaction. All the compounds were characterized by 1H NMR, 13C NMR and MS techniques.

参考文献

[1] (a) Mcintosh, E. N.; Purko, M.; Wood, W. A. J. Biol. Chem. 1957, 228, 449.

(b) Yang, Y. H.; Xiao, C. L. Chem. Life 2008, 28, 448 (in Chinese).

(杨延辉, 肖春玲, 生命的化学, 2008, 28, 448.)

[2] Mdluli, K.; Spigelman, M. Curr. Opin. Pharmacol. 2006, 6, 459.

[3] Webb, M. E.; Smith, A. G.; Abell, C. Nat. Prod. Rep. 2004, 21, 695.

[4] Somu, R. V.; Boshoff, H.; Qiao, C.; Bennett, E. M.; Barry III, C. E.; Aldrich, C. C. J. Med. Chem. 2006, 49, 31.

[5] Tuck, K. L.; Saldanha, S. A.; Birch, L. M.; Smith, A. G.; Abell, C. Org. Biomol. Chem. 2006, 4, 3606.

[6] Yan, Z. H.; Lai, K. M.; Tian, W. S.; Yu, Z. X. Acta Chim. Sinica 2012, 70, 1322 (in Chinese).

(严兆华, 赖焜民, 田伟生, 余章昕, 化学学报, 2012, 70, 1322.)

[7] Yang, X. Y.; Lv, T. M.; Zhu, S. J.; Wu, F. H. Acta Chim. Sinica 2011, 69, 815 (in Chinese).

(杨雪艳, 吕铁梅, 朱胜杰, 吴范宏, 化学学报, 2011, 69, 815.)

[8] Kumaki, Y.; Day, C. W.; Smee, D. F.; Morrey, J. D.; Barnard, D. L. Antiviral Res. 2011, 92, 329.

[9] Mandel, A. L.; La Clair, J. J.; Burkart, M. D. Org. Lett. 2004, 6, 4802.

[10] Woo, S. H.; Frechette, S.; Khalil, E. A.; Bouchain, G.; Vaisburg, A.; Bernstein, N.; Moradei, O.; Leit, S.; Allan, M.; Fournel, M.; Trachy-Bourget, M. C.; Li, Z. M.; Besterman, J. M.; Delorme, D. J. Med. Chem. 2002, 45, 2882.

[11] Hon, Y. S.; Wong, Y. C.; Chang, C. P.; Hsieh, C. H. Tetrahedron 2007, 63, 11329.

[12] Neres, J.; Labello, N. P.; Somu, R. V.; Boshoff, H. I.; Wilson, D. J.; Vannada, J.; Chen, L. Q.; Barry III, C. E.; Bennett, E. M.; Aldrich, C. C. J. Med. Chem. 2008, 51, 5357.

[13] Xu, Z. X.; Yin, W.; Chen, J. L.; Qiao, C. H. Chin. J. Org. Chem. 2013, 33, 1578 (in Chinese).

(许芝祥, 尹伟, 陈晶磊, 乔春华, 有机化学, 2013, 33, 1578.)

文章导航

/